Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. blood bone
Show results for
Products
Services

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Blood Bone Articles & Analysis: Older

10 news found

Alfa Chemistry Enriches API Supply by Adding Lenalidomide, Parecoxib Sodium, and Rivaroxaban

Alfa Chemistry Enriches API Supply by Adding Lenalidomide, Parecoxib Sodium, and Rivaroxaban

” Lenalidomide The lenalidomide API provided by Alfa Chemistry can be used in research applications or medication production for the treatment of cancerous and anemia patients who are suffering from certain blood/bone marrow disorders. Lenalidomide, as an oral immunomodulatory drug, revealed a good safety profile. ...

ByAlfa Chemistry


Rarecells, Inc. to fund a clinical study at Columbia University of its ISET® -AML test for early detection of Acute Myeloid Leukemia (AML)

Rarecells, Inc. to fund a clinical study at Columbia University of its ISET® -AML test for early detection of Acute Myeloid Leukemia (AML)

Myelodysplastic syndromes are a group of diverse bone marrow disorders in which the bone marrow does not produce enough healthy blood cells. ...

ByRarecells Diagnostics SAS


Genenta Data Presentation at AACR to Describe On-Target Biological Activity of Temferon™ in Unmethylated Glioblastoma Multiforme

Genenta Data Presentation at AACR to Describe On-Target Biological Activity of Temferon™ in Unmethylated Glioblastoma Multiforme

One month after administration of the highest tested dose so far, the hematopoietic system of Temferon-treated patients was composed of up to 30% gene modified cells, as detected in peripheral blood and bone marrow cells. The gene-modified differentiated cells persisted for up to 18 months, albeit at lower levels. ...

ByGenenta Science


AlloVir Reports First Quarter 2022 Financial Results

AlloVir Reports First Quarter 2022 Financial Results

” Recent Highlights At the Annual Meeting of the European Society for Blood and Bone Marrow Transplantation (EBMT) in March 2022, AlloVir reported updated preliminary data from the open-label Phase 2 study assessing the safety and efficacy of posoleucel for multi-virus prevention in high-risk allo-HCT patients. ...

ByKalaris


Genenta ASGCT Clinical Data Highlights Temferon™ Biological Effects in Glioblastoma

Genenta ASGCT Clinical Data Highlights Temferon™ Biological Effects in Glioblastoma

Based on the persistence of cells in the peripheral blood and bone marrow up to 18 months we conclude that Temferon successfully engrafts, and no drug-limiting toxicities have been identified. The ability of Temferon cells to find their way from bone marrow to the tumor site is supported by the presence of gene-marked cells in the tumor resected ...

ByGenenta Science


LAVA Therapeutics Receives FDA Orphan Drug Designation for LAVA-051 for the Treatment of Chronic Lymphocytic Leukemia

LAVA Therapeutics Receives FDA Orphan Drug Designation for LAVA-051 for the Treatment of Chronic Lymphocytic Leukemia

CLL is a form of leukemia characterized by progressive accumulation of abnormal lymphocytes in the peripheral blood, bone marrow and lymphoid tissues. "We are excited to receive our first orphan drug designation from the FDA for LAVA-051, our most advanced product candidate from our off-the-shelf GammabodyTM platform that is designed to unlock the full ...

ByLAVA Therapeutics N.V.


Abologix obtains positive pre-clinical proof-of-concept results with its monoclonal antibody H225

Abologix obtains positive pre-clinical proof-of-concept results with its monoclonal antibody H225

In this study the efficacy of rH225 was tested by assessing: the delayed mortality upon Jeko-1 MCL cell injection and the reduction of Jeko-1 cells burden in the blood, spleen, lymph nodes, bone marrow and liver rH225 delayed significantly the body weight loss and the onset of clinical disease signs in mice inoculated with Jeko-1 MCL cells. ...

ByAbologix


10 Fascinating Facts About Myofascial Release (MFR)

10 Fascinating Facts About Myofascial Release (MFR)

Fascia forms a three-dimensional web running through and around all body structures including muscles, nerves, blood vessels, bones and organs. Fascia is stronger than it looks Seen under a microscope fascia looks very fragile, but it has a tensile strength of 2,000lb per square inch. ...

ByDSmedi, Inc.


Translating great stem cell ideas into effective therapies

Translating great stem cell ideas into effective therapies

They got almost $4.5 million for their research helping people with sickle cell anemia, an inherited blood disorder that causes intense pain, and can result in strokes and organ damage. ...

ByAnkasa Regenerative Therapeutics


Congratulations to Dave Harry on his Swimathon 2015

Congratulations to Dave Harry on his Swimathon 2015

Ehlers-Danlos syndrome is a group of disorders that affect connective tissues, these are the tissues that support the skin, bones, blood vessels and other organs. Defects in connective tissues cause the signs and symptoms of Ehlers-Danlos syndrome which can vary from mildly loose joints to life-threatening complications. ...

ByEco Environmental Services Ltd

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT